Elucidating GPCR Functional Selectivity: Novel Opportunities for Drug Development

The New York Academy of Sciences
Tuesday, September 30, 2014
Explore the paradigm of GPCR ligand bias in the brain and the use of dopamine receptor agonists in the treatment of psychiatric disorders.

New Frontiers in the Neurobiology of Mental Illness

The New York Academy of Sciences
Friday, October 10, 2014
Explore the translation of neuroscientific breakthroughs into therapies for mental illnesses such as schizophrenia, depression, fear and anxiety disorders, and autism. Free event—Advance registration required.

Unraveling the Mysteries of Creativity: Connections to Genetics, Mental Health, and the Brain

American Folk Art Museum, New York City
Thursday, October 16, 2014
Artist Willem van Genk was diagnosed with both autism and schizophrenia. How did these states of mind impact and inform his art? Harvard-trained psychologist Dr. Shelley Carson will discuss the relationship between creativity and mental disorders such as schizophrenia, bipolar disorder, and autism, and will explain a “shared vulnerability” model of this relationship, in which a predisposition to certain mental disorders may confer benefits to creativity by reducing cognitive inhibitions that normally restrict access to unconscious material. Janos Martin, director of the Living Museum, will speak about the studio center for patients he founded at Creedmore Hospital. Dr. Sharon Thompson Schill, co-director, Center for Cognitive Neuroscience, University of Pennsylvania, will explain the “hyperfrontality” theory as well as the costs and benefits of attentional focus for cognition. Kenneth M. Heilman, M.D., the James E. Rooks Jr. Distinguished Professor of Neurology, University of Florida College of Medicine, will discuss his latest book, Creativity and The Brain. Aimee Lee Ball will moderate the discussion.Space is limited; registration required.

Pharmacologic Resolution of Inflammation as a Novel Therapeutic Approach

The New York Academy of Sciences
Tuesday, October 28, 2014
As Alzheimer’s disease is now recognized as an ‘inflammatory disease’, inflammatory macrophages offer opportunities for resolution-based pharmacology.

Gene Network Changes in Alzheimer’s Disease: Potential Points for Therapeutic Intervention

The New York Academy of Sciences
Monday, November 03, 2014
Next-generation sequencing of Alzheimer’s disease progression reveals gene network changes within microglial pathways, the understanding of which is critical.

Shaping the Developing Brain: Prenatal through Early Childhood

The New York Academy of Sciences
Tuesday, November 11, 2014 - Thursday, November 13, 2014
The fifth annual Aspen Brain Forum will highlight educational practices, health and nutrition practices, applied research, and government policy with the potential for enhancing healthy brain development and improving outcomes for at-risk children.

2014 International Neuroethics Society Annual Meeting

AAAS, Washington, DC
Thursday, November 13, 2014 - Friday, November 14, 2014
This two-day annual meeting features a public program on Thursday, November 13, “Neuroscience Knowledge and the Robotic Mind,” and several expert panels the following day. Panel topics include the BRAIN Initiative, neuroscience and the courts, and neuroscience and human rights.

Call for Nominations–10th IBRO/Kemali Prize

Wednesday, April 15, 2015
The Tenth International Prize of 25,000 Euros will be awarded in 2015 by the IBRO-Dargut & Milena Kemali Foundation to a scientist less than 45 years of age on December 31, 2014 who has made outstanding contributions to Basic or Clinical Neuroscience. Nominations in electronic format should be submitted by email to ibrokemaliprize@gmail.com and ibrocentral@gmail.com. Self-nominations are welcome. They should be received by April 15, 2015.